Efficacy of Therapeutic-Dose Heparin for Thromboprophylaxis in Hospitalized Patients With COVID-19
7/10/2021
0:00
17:22
Interview with Alex C. Spyropoulos, author of Efficacy and Safety of Therapeutic-Dose Heparin vs Standard Prophylactic or Intermediate-Dose Heparins for Thromboprophylaxis in High-risk Hospitalized Patients With COVID-19: The HEP-COVID Randomized Clinical Trial
Otros episodios de "Coronavirus (COVID-19) Q&A"
No te pierdas ningún episodio de “Coronavirus (COVID-19) Q&A”. Síguelo en la aplicación gratuita de GetPodcast.